Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederinvestor.jazzpharma.com
Jazz Pharmaceuticals plc News Releases
Get the latest updates from Jazz Pharmaceuticals plc News Releases directly as they happen.
Follow now 54 followers
Latest posts
Last updated 4 days ago
Jazz Pharmaceuticals Announces First Quarter 2025 Financial Results and Updates 2025 Financial Guidance
4 days ago
– Total revenues of $898 million in 1Q25 –– Xywav® and Epidiolex®...
Jazz Pharmaceuticals to Participate in the BofA Securities 2025 Healthcare Conference
10 days ago
DUBLIN , April 30, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ)...
Jazz Pharmaceuticals Receives CHMP Positive Opinion for Zanidatamab for the Treatment of Advanced HER2-Positive Biliary Tract Cancer
15 days ago
DUBLIN , April 25, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ)...
Jazz Pharmaceuticals Showcases Transformative Data at ASCO 2025, Highlighting Advances in Small Cell Lung Cancer, HER2+ Gastroesophageal Cancer and Diffuse Glioma
17 days ago
Statistically significant and clinically meaningful progression-free survival (PFS) and overall survival (OS)...
Jazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025
18 days ago
DUBLIN , April 22, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ)...
Jazz Pharmaceuticals Completes Acquisition of Chimerix
19 days ago
- Addition of dordaviprone strengthens Jazz's late-stage oncology pipeline and reinforces commitment...
Jazz Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference
about 1 month ago
DUBLIN , March 26, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ)...
Jazz Pharmaceuticals to Showcase Research Demonstrating Treatment Benefits of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution and Epidiolex® (cannabidiol) at American Academy of Neurology Annual Meeting
about 2 months ago
Updated top-line results demonstrate improved outcomes in adults with narcolepsy or idiopathic...
Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio
2 months ago
-Dordaviprone addresses a significant unmet patient need for patients with rare, high-grade...
Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2024 Financial Results and Provides 2025 Financial Guidance
2 months ago
– Record total revenues of $4.1 billion in 2024 and $1.1 billion...
Jazz Pharmaceuticals to Participate in TD Cowen's 45th Annual Health Care Conference
3 months ago
DUBLIN , Feb. 20, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ)...
Jazz Pharmaceuticals to Report 2024 Full Year and Fourth Quarter Financial Results on February 25, 2025
3 months ago
DUBLIN , Feb. 11, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ)...